Literature DB >> 20431558

Market watch: emerging companion diagnostics for cancer drugs.

Jocelyn August1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20431558     DOI： 10.1038/nrd3173

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Novel anticancer strategy targets DNA repair.

Authors:  Alisa Opar
Journal:  Nat Rev Drug Discov       Date:  2009-06       Impact factor: 84.694
  1 in total
  6 in total

Review 1.  Biomarkers to guide clinical therapeutics in rheumatology?

Authors:  William H Robinson; Rong Mao
Journal:  Curr Opin Rheumatol       Date:  2016-03       Impact factor: 5.006

Review 2.  Using electronic health records to drive discovery in disease genomics.

Authors:  Isaac S Kohane
Journal:  Nat Rev Genet       Date:  2011-05-18       Impact factor: 53.242

Review 3.  Strategies to overcome resistance to epidermal growth factor receptor monoclonal antibody therapy in metastatic colorectal cancer.

Authors:  Woo-Jeong Jeong; Pu-Hyeon Cha; Kang-Yell Choi
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 4.  Molecular biomarkers for grass pollen immunotherapy.

Authors:  Florin-Dan Popescu
Journal:  World J Methodol       Date:  2014-03-26

Review 5.  Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing.

Authors:  Frank S Ong; Kingshuk Das; Jay Wang; Hana Vakil; Jane Z Kuo; Wendell-Lamar B Blackwell; Stephen W Lim; Mark O Goodarzi; Kenneth E Bernstein; Jerome I Rotter; Wayne W Grody
Journal:  Expert Rev Mol Diagn       Date:  2012-07       Impact factor: 5.225

Review 6.  Predictive biomarkers: a paradigm shift towards personalized cancer medicine.

Authors:  Nicholas B La Thangue; David J Kerr
Journal:  Nat Rev Clin Oncol       Date:  2011-08-23       Impact factor: 66.675
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.